We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DY icon
5126
Dycom Industries
DY
$12B
$364K ﹤0.01%
7,711
+740
+11% +$36K
ENTA icon
5127
Enanta Pharmaceuticals
ENTA
$402M
$364K ﹤0.01%
5,893
-21,680
-79% -$1.34M
CCD
5128
Calamos Dynamic Convertible & Income Fund
CCD
$741M
$362K ﹤0.01%
17,125
-1,200
-7% -$24.9K
MCBS icon
5129
MetroCity Bankshares
MCBS
$1.02B
$362K ﹤0.01%
+20,648
New +$309K
MITK icon
5130
Mitek Systems
MITK
$837M
$362K ﹤0.01%
47,308
+17,415
+58% +$147K
SMHI icon
5131
SEACOR Marine Holdings
SMHI
$263M
$362K ﹤0.01%
26,249
+11,744
+81% +$153K
CHRS icon
5132
PUT
Coherus Oncology
CHRS
$192M
$360K ﹤0.01%
20,000
+11,000
+122% +$203K
MNOV icon
5133
MediciNova
MNOV
$65M
$360K ﹤0.01%
53,418
+27,703
+108% +$208K
ROAD icon
5134
Construction Partners
ROAD
$6.71B
$359K ﹤0.01%
21,251
+10,881
+105% +$191K
WIA
5135
Western Asset Inflation-Linked Income Fund
WIA
$186M
$359K ﹤0.01%
29,545
+9,699
+49% +$115K
ADRE
5136
DELISTED
Invesco BLDRS Emerging Markets 50 ADR Index Fund
ADRE
$359K ﹤0.01%
8,117
+542
+7% +$22.4K
ARR
5137
PUT
Armour Residential REIT
ARR
$2.34B
$357K ﹤0.01%
+4,000
New +$342K
GEOS icon
5138
Geospace Technologies
GEOS
$72.8M
$357K ﹤0.01%
21,257
+7,759
+57% +$118K
XT icon
5139
iShares Future Exponential Technologies ETF
XT
$3.99B
$357K ﹤0.01%
8,355
+687
+9% +$28K
TELL
5140
DELISTED
Tellurian Inc.
TELL
$357K ﹤0.01%
49,062
-6,256
-11% -$47.6K
BGG
5141
DELISTED
Briggs & Stratton Corp.
BGG
$356K ﹤0.01%
53,515
+40,059
+298% +$246K
IRR
5142
DELISTED
VOYA NATURAL RESOURCES EQUITY INCOME FUND
IRR
$356K ﹤0.01%
86,566
+57,905
+202% +$223K
CCRD
5143
DELISTED
CoreCard
CCRD
$355K ﹤0.01%
8,892
+3,653
+70% +$158K
FSBW icon
5144
FS Bancorp
FSBW
$316M
$355K ﹤0.01%
11,142
+3,280
+42% +$95.1K
COLO
5145
Global X MSCI Colombia ETF
COLO
$209M
$355K ﹤0.01%
9,026
-238
-3% -$8.89K
CALA
5146
DELISTED
Calithera Biosciences, Inc
CALA
$355K ﹤0.01%
3,108
+1,198
+63% +$90.1K
PGNX
5147
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$355K ﹤0.01%
69,683
-95,057
-58% -$503K
IBCE
5148
DELISTED
iShares iBonds Mar 2023 Term Corporate ex-Financials ETF
IBCE
$355K ﹤0.01%
14,448
-9,274
-39% -$228K
RUBY
5149
DELISTED
Rubius Therapeutics, Inc
RUBY
$354K ﹤0.01%
37,222
+27,261
+274% +$264K
EML icon
5150
Eastern Company
EML
$149M
$353K ﹤0.01%
11,576
+2,300
+25% +$64.4K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.